SCHEMBL4746229

SCHEMBL4746229

COc1cccc(-c2ccccc2CC=O)c1OC

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
HTR2A P28223 1/20 0.42
HTR2C P28335 1/20 0.42
KDM4E B2RXH2 3/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
P2RX7 Q99572 1/20 0.41
ALDH1A1 P00352 1/20 0.41
ATM Q13315 1/20 0.41
ABCB1 P08183 2/20 0.40
ABCG2 Q9UNQ0 1/20 0.40
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA14 Q9ULX7 1/20 0.40
NFE2L2 Q16236 1/20 0.40
CHRM2 P08172 1/20 0.40
CHRM1 P11229 1/20 0.40
CHRM3 P20309 1/20 0.40
HDAC4 P56524 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1957955 0.87 HTR7 (0.46) ALDH1A1CA12CA1CA2CA14
SCHEMBL5205282 0.85 CA12 (0.49) MEN1KMT2AKDM4EL3MBTL1ALDH1A1
SCHEMBL9287986 0.83 P2RX7 (0.45) MEN1KMT2AHTR2AHTR2CKDM4E
SCHEMBL29957820 0.79 ALDH1A1 (0.54) KDM4EL3MBTL1ALDH1A1CHRM2CHRM1
SCHEMBL249539 0.79 ALDH1A1 (0.54) KDM4EL3MBTL1ALDH1A1CHRM2CHRM1
SCHEMBL29143297 0.79 HTR2A (0.45) MEN1KMT2AHTR2AHTR2CKDM4E
SCHEMBL16674078 0.77 CA1 (0.55) KDM4EALDH1A1CA12CA1CA2
SCHEMBL196440 0.77 MGAM (0.55) KDM4EALDH1A1CA12CA1CA2
SCHEMBL6767194 0.76 HTR7 (0.50) HTR2AHTR2CKDM4EHTR1A
SCHEMBL6536022 0.76 ERN1 (0.54) KDM4EALDH1A1CA1CA2NFE2L2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008123821-A1 4, 5-DIHYDRO-LH-IMIDAZOL-2-AMINE DERIVATIVES FOR USE IN THE TREATMENT OF RESPIRATORY, CARDIOVASCULAR, NEUROLOGICAL OR GASTROINTESTINAL DISORDERS ALBIREO AB (SE) 2008-10-16 WO disclosed